These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23327199)

  • 1. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.
    Wu J; Zhou L; Liu J; Ma G; Kou Q; He Z; Chen J; Ou-Yang B; Chen M; Li Y; Wu X; Gu B; Chen L; Zou Z; Qiang X; Chen Y; Lin A; Zhang G; Guan X
    Crit Care; 2013 Jan; 17(1):R8. PubMed ID: 23327199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.
    Liu F; Wang HM; Wang T; Zhang YM; Zhu X
    BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis.
    Li C; Bo L; Liu Q; Jin F
    Int J Infect Dis; 2015 Apr; 33():90-6. PubMed ID: 25532482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Therapeutic Effects of Thymosin α1 Combined with Human Immunoglobulin (Ig) and Bundles on Severe Sepsis: a Retrospective Study.
    Li Y; Li CS
    Clin Lab; 2015; 61(8):907-16. PubMed ID: 26427133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Si-ni-tang (a Chinese herbal formula) for improving immunofunction in sepsis: study protocol for a pilot randomized controlled trial.
    Zeng R; Zheng Y; Fan R; Zhou G; Zhang Y; Mai S; Xie D; Weng Y; Du J; Han Y; Lai F
    Trials; 2019 Aug; 20(1):537. PubMed ID: 31462310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune and inflammation confusion in severe sepsis and effects of bi-immunomodulation therapy: a prospective, randomized, controlled clinical trial].
    Zhou LX; Tan JJ; Li YN; Luo HT; Shao YH; Qiang XH; Yu TO; Ma MY; Mao KJ; Fang B
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(15):1028-33. PubMed ID: 19595251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study.
    Chen H; He MY; Li YM
    Chin Med J (Engl); 2009 Apr; 122(8):883-8. PubMed ID: 19493408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ulinastatin combined with thymosin alpha1 on sepsis: A systematic review and meta-analysis of Chinese and Indian patients.
    Liu D; Yu Z; Yin J; Chen Y; Zhang H; Xin F; Fu H; Wan B
    J Crit Care; 2017 Jun; 39():259-266. PubMed ID: 28069319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulinastatin and/or thymosin α1 for severe sepsis: A systematic review and meta-analysis.
    Feng Z; Shi Q; Fan Y; Wang Q; Yin W
    J Trauma Acute Care Surg; 2016 Feb; 80(2):335-40. PubMed ID: 26517783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
    Srisawat N; Tungsanga S; Lumlertgul N; Komaenthammasophon C; Peerapornratana S; Thamrongsat N; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Kellum JA
    Crit Care; 2018 Oct; 22(1):279. PubMed ID: 30367647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin alpha 1 treatment for patients with sepsis.
    Pei F; Guan X; Wu J
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):71-76. PubMed ID: 30063866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin alpha 1 is associated with improved cellular immunity and reduced infection rate in severe acute pancreatitis patients in a double-blind randomized control study.
    Wang X; Li W; Niu C; Pan L; Li N; Li J
    Inflammation; 2011 Jun; 34(3):198-202. PubMed ID: 20549321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial.
    Iino S; Toyota J; Kumada H; Kiyosawa K; Kakumu S; Sata M; Suzuki H; Martins EB
    J Viral Hepat; 2005 May; 12(3):300-6. PubMed ID: 15850471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin α1 plus routine treatment inhibit inflammatory reaction and improve the quality of life in AECOPD patients.
    Jia Z; Feng Z; Tian R; Wang Q; Wang L
    Immunopharmacol Immunotoxicol; 2015; 37(4):388-92. PubMed ID: 26250523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study.
    Liu J; Shen Y; Wen Z; Xu Q; Wu Z; Feng H; Li Z; Dong X; Huang S; Guo J; Zhang L; Chen Y; Li W; Zhu W; Du H; Liu Y; Wang T; Chen L; Teboul JL; Annane D; Chen D
    Front Immunol; 2021; 12():673693. PubMed ID: 34408744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
    Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H
    Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulinastatin- and thymosin α1-based immunomodulatory strategy for sepsis: A meta-analysis.
    Han D; Shang W; Wang G; Sun L; Zhang Y; Wen H; Xu L
    Int Immunopharmacol; 2015 Dec; 29(2):377-382. PubMed ID: 26522590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with thymosin alpha1 and dexamethasone helps mice survive sepsis.
    Xiang XS; Li N; Zhao YZ; Li QR; Li JS
    Inflammation; 2014 Apr; 37(2):402-16. PubMed ID: 24122349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study.
    Mutchnick MG; Lindsay KL; Schiff ER; Cummings GD; Appelman HD; Peleman RR; Silva M; Roach KC; Simmons F; Milstein S; Gordon SC; Ehrinpreis MN
    J Viral Hepat; 1999 Sep; 6(5):397-403. PubMed ID: 10607256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of continuous blood purification and thymosin alpha1 on the cellular immunity in patients with severe sepsis: a prospective, randomized, controlled clinical trial].
    Li YN; Zhou LX; Qiang XH; Yu TO; Mao KJ; Feng B; Wen WB; Zou YC; Li WY; Li C
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):139-42. PubMed ID: 19278581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.